PDE8B and adrenal cortex neoplasm: In addition, in a case-control study of 216 unrelated patients with adrenocortical tumors and 192 controls, nine different PDE8B sequence changes were identified in the patients and controls, with two variations that were seen only in the patient group, demonstrating significant potential to impair protein function in vitro and in silico [19].